Clinical Trials in Amiens, France
372 recruiting
Showing 1–20 of 426 trials
Recruiting
Not Applicable
DVT Burden and the Risk of Post-thrombotic Syndrome
Postthrombotic Syndrome
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer400 enrolled27 locationsNCT06385353
Recruiting
Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock?
Acute Kidney InjurySeptic Shock
Centre Hospitalier Universitaire, Amiens110 enrolled1 locationNCT03547414
Recruiting
Access to Kidney Transplant of Obese Patients Beginning Dialysis
Obese PatientsComorbiditiesDialysis+1 more
Centre Hospitalier Universitaire, Amiens100 enrolled1 locationNCT04748770
Recruiting
Efficacy at One Year of Combined Injections of Plasma Rich in Platelets and Hyaluronic Acid in Knee Osteoarthritis
Knee OsteoarthritisHyaluronic AcidPlatelet-Rich Plasma
Centre Hospitalier Universitaire, Amiens100 enrolled1 locationNCT05039463
Recruiting
Phase 3
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
CandidemiaCandidiasis, Invasive
Basilea Pharmaceutica450 enrolled143 locationsNCT05421858
Recruiting
Follow-up of a Cohort of Patients With Aortic Valve Bicuspidia
Aortic Valve, Bicuspid
Centre Hospitalier Universitaire, Amiens232 enrolled1 locationNCT03139786
Recruiting
TIMP2*IGFBP7 and Transient AKI
Septic Shock
Centre Hospitalier Universitaire, Amiens190 enrolled1 locationNCT03472079
Recruiting
Impact of COMORBIDities After Radical Cystectomy Using a Predictive Method With Artificial Intelligence
Bladder CancerDeep LearningComorbidity
Centre Hospitalier Universitaire, Amiens500 enrolled1 locationNCT05204186
Recruiting
Study of the Prognosis of Infectious Endocarditis (EPEI)
Endocarditis Infective
Centre Hospitalier Universitaire, Amiens645 enrolled1 locationNCT03211975
Recruiting
Characteristics and Prognosis of Moderate or Severe Tricuspid Regurgitation
Tricuspid Valve Disease
Centre Hospitalier Universitaire, Amiens400 enrolled1 locationNCT03546231
Recruiting
Prevalence and Clinical Significance of Anti-annexin A2 Antibodies in COVID-19 Infection
COVID-19
Centre Hospitalier Universitaire, Amiens300 enrolled1 locationNCT05242159
Recruiting
Spectroscopic Analysis of Tongue Tumor Samples.
Squamous Cell CarcinomaOral CavityMass Spectroscopy+3 more
Centre Hospitalier Universitaire, Amiens33 enrolled1 locationNCT05104619
Recruiting
Not Applicable
Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical Ischaemia Stage
Peripheral Artery DiseaseMajor Adverse Cardiovascular EventsMajor Adverse Limb Events+2 more
Centre Hospitalier Universitaire, Amiens134 enrolled1 locationNCT06318767
Recruiting
Phase 2
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Asthma
Sanofi1,147 enrolled229 locationsNCT06676319
Recruiting
Efficacy and Safety of iStent Inject and Inject W in the Management of Primary Open-angle Glaucoma
POAGMIGS
Centre Hospitalier Universitaire, Amiens100 enrolled1 locationNCT05062668
Recruiting
Phase 3
Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children
Chronic PainNeuropathic Pain
University Hospital, Brest46 enrolled10 locationsNCT05997979
Recruiting
Phase 3
Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Marginal Zone Lymphoma
The Lymphoma Academic Research Organisation260 enrolled48 locationsNCT06006117
Recruiting
Not Applicable
Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients With Pulmonary Embolism (PRONOSPECT)
Venous ThromboembolismPulmonary Embolism
University Hospital, Brest665 enrolled13 locationsNCT06372730
Recruiting
Valvular Aortic Stenosis Prognosis Study
Morality
Centre Hospitalier Universitaire, Amiens3,450 enrolled1 locationNCT03628313
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Non-small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC614 enrolled220 locationsNCT06170788